Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let’s stay connected!
To submit a correction request, please visit our Contact Us page.
Results from Phase III clinical trials have demonstrated that BRENZAVVY significantly lowers haemoglobin A1c and fasting blood sugar levels over 24 weeks. Credit: Dragana Gordic/Shutterstock.
ScottsMiracle-Gro Announces Fiscal 2023 Full-Year Results Full-year total Company net sales of $3.55 billion in line with guidance Free cash flow of $438 million improved
Telehealth claims data suggest service duplication, Roche app to evaluate MS symptom
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let’s stay connected!
To submit a correction request, please visit our Contact Us page.
TheracosBio to introduce BRENZAVVY in sub-Saharan Africa
Results from Phase III clinical trials have demonstrated that BRENZAVVY significantly lowers haemoglobin A1c and fasting blood sugar levels over 24 weeks. Credit: Dragana Gordic/Shutterstock.
Hawthorne Gardening Q4 Revenue Slips 3% Sequentially
ScottsMiracle-Gro Announces Fiscal 2023 Full-Year Results Full-year total Company net sales of $3.55 billion in line with guidance Free cash flow of $438 million improved
LetsGetChecked secures first FDA authorization for at-home chlamydia and gonorrhea test
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration